Related Experiment Video
Updated: Apr 17, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Cost and Outcome in Pediatric Ischemic Stroke
William Hamilton1, Haijuan Huang2, Eric Seiber3
1Department of Pediatrics, The Ohio State University and Nationwide Children's Hospital, Columbus, OH, USA.
Insights
Childhood stroke costs vary significantly by type and cause. Associated diseases and stroke type impact expenses, with higher costs linked to worse patient outcomes and quality of life.
Area of Science:
- Pediatric Neurology
- Health Economics
Background:
- Childhood stroke costs are often overlooked.
- Understanding cost drivers is crucial for resource allocation and patient care.
Purpose of the Study:
- To investigate factors influencing the cost of pediatric stroke.
- To determine if stroke type, associated conditions, or age at onset affect healthcare costs and patient outcomes.
Main Methods:
- Retrospective review of 111 pediatric stroke cases (arterial ischemic stroke or sinovenous thrombosis) from 2005-2010.
- Cost analysis for the year following stroke.
- Outcome assessment using the Recovery and Recurrence Questionnaire and Pediatric Quality of Life Inventory for 46 patients.
Main Results:
- Neonatal strokes were less costly than childhood strokes.
- Strokes associated with congenital heart disease or vasculopathy incurred the highest costs.
- Perinatal or idiopathic strokes were the least expensive.
- Increased healthcare costs correlated with greater impairment and reduced quality of life.
Conclusions:
- Stroke etiology is a significant determinant of pediatric stroke costs.
- Cost-benefit analyses for pediatric stroke must account for the specific cause of the stroke.
- Findings highlight the economic burden of pediatric stroke and the need for etiology-specific cost considerations.
Abstract:
The cost of childhood stroke receives little notice. The authors examined potential drivers of cost and outcome to test whether (1) neonatal strokes cost less than childhood strokes, (2) associated diseases influence cost, (3) arterial ischemic stroke is more costly than sinovenous thrombosis, and (4) cost correlates with outcome. The authors reviewed records of 111 children who sustained arterial ischemic stroke or sinovenous thrombosis between 2005 and 2010 to identify costs for the following year. They assessed outcomes in 46 with the Recovery and Recurrence Questionnaire and the Pediatric Quality of Life Inventory. Neonatal strokes cost less than childhood stroke. Strokes associated with congenital heart disease or vasculopathy cost the most, while perinatal or idiopathic strokes cost the least. Higher costs are correlated with worse impairment and poorer quality of life. Stroke etiology significantly influences the cost of pediatric stroke. Future cost-benefit studies must consider etiology when estimating the incremental costs associated with stroke.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...

